Triplixam antihypertensive medication

Triplixam is a fixed-dose combination medication used to treat hypertension (high blood pressure). It combines three active ingredients: perindopril arginine, indapamide, and amlodipine besylate. This allows patients to manage their condition with a single daily tablet instead of multiple pills.

The brand was developed and is owned by Servier, a major French pharmaceutical company and the largest independent French pharmaceutical group. While Servier's global headquarters and primary research facilities are situated in France, Triplixam is produced in various manufacturing sites worldwide to serve international markets. In Brazil, it is distributed and marketed through its local subsidiary, Laboratórios Servier do Brasil. Servier is unique in the pharmaceutical industry as it is governed by a non-profit foundation, ensuring its independence and primary focus on medical research and development.